{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:31:17Z","timestamp":1790872277898,"version":"4.1.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2000,3,15]]},"DOI":"10.1001\/jama.283.11.1445","type":"journal-article","created":{"date-parts":[[2003,3,18]],"date-time":"2003-03-18T10:05:58Z","timestamp":1047981958000},"page":"1445","source":"Crossref","is-referenced-by-count":198,"title":["Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected Persons&lt;SUBTITLE&gt;An International Randomized Trial&lt;\/SUBTITLE&gt;"],"prefix":"10.1001","volume":"283","author":[{"given":"Fred","family":"Gordin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/192501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T13:40:48Z","timestamp":1481809248000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.283.11.1445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,15]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,3,15]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.283.11.1445","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3,15]]}}}